Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDC drug survey

This article was originally published in The Tan Sheet

Executive Summary

Acetaminophen was the most frequently used generic drug ordered or provided by physicians at office visits in 2000, according to the "National Ambulatory Medical Care Survey: 2000 Summary." Donald Cherry, et al., Division of Health Care Statistics, CDC, found acetaminophen (Rx and OTC) in 3.2% of drug mentions. McNeil's Tylenol was the sixth most ordered branded drug (1% of total); Schering-Plough's Claritin was the top prescribed medication, accounting for 17.1 mil. drug mentions (1.4% of total). The NAMCS, a national probability sample survey, was conducted from Dec. 27, 1999 to Dec. 24, 2000 and appears in CDC's June 5 Advance Data From Vital & Health Statistics...

Acetaminophen was the most frequently used generic drug ordered or provided by physicians at office visits in 2000, according to the "National Ambulatory Medical Care Survey: 2000 Summary." Donald Cherry, et al., Division of Health Care Statistics, CDC, found acetaminophen (Rx and OTC) in 3.2% of drug mentions. McNeil's Tylenol was the sixth most ordered branded drug (1% of total); Schering-Plough's Claritin was the top prescribed medication, accounting for 17.1 mil. drug mentions (1.4% of total). The NAMCS, a national probability sample survey, was conducted from Dec. 27, 1999 to Dec. 24, 2000 and appears in CDC's June 5 Advance Data From Vital & Health Statistics....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094140

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel